GENB Generate Biomedicines leadership flags accelerated AI drug pipeline advancement as top priority in latest quarterly earnings update EUDA EUDA management outlines new digital health expansion priorities alongside latest quarterly earnings TFSL TFS reports 109 negative Q1 2026 EPS surprise shares edge down 034 today PHVS Pharvaris NV shares climb nearly 5 percent despite fourth quarter 2025 earnings missing analyst estimates Kinder Morgan KMI High Free Cash Flow Midstream Operator Faces Valuation Headwinds Amid Peer Underperformance